Clinicians may consider using the nearest available tablet strength (100 mg or 150 mg) to avoid the need for 3TC oral solution, thereby simplifying ARV regimens and facilitating adherence …

While combination antiretroviral (ARV) treatments reduce CKD in the HIV-infected population overall, some ARV drugs have been shown to be nephrotoxic and associated with worsening …

Acute kidney injury (AKI) is frequent in HIV and is commonly the result of sepsis, dehydration and drug toxicities. Furthermore, HIV itself increases the risk of chronic kidney disease (CKD). …

HIV-infected patients treated with TAF remain at high risk of CKD and should be screened regularly for renal risk factors, and for the presence of CKD. There is also some evidence to …

Combination antiretroviral therapy (cART) remains the cornerstone of treatment. However, little is known about the impact of cART on disease outcomes in patients with HIV-associated …

2017年12月7日 · Patients living with HIV have an increased risk of chronic kidney disease (CKD) by comparison with the general age-matched population, for various reasons including the use …

2017年1月7日 · Tenofovir disoproxil fumarate (TDF) is considered to play a significant role in the development of CKD in these patients. It has been proposed that tenofovir alafenamide (TAF), …

2024年1月5日 · People with human immunodeficiency virus (HIV) are at risk for chronic kidney disease (CKD) due to HIV and antiretroviral therapy (ART) nephrotoxicity. Immediate ART …

•What is/are the most likely cause(s) of her chronic kidney disease? •What target BP and HbA1c should you aim for in this patient? •Should you check the protein: creatinine ratio? What …

2016年4月30日 · Selected antiretroviral agents, especially tenofovir disoproxil fumarate (TDF) and some ritonavir-boosted protease inhibitors (PI/rs), have been associated with increased risk of …